Trials / Completed
CompletedNCT05976698
LSD-Perceptual-Choice-Study
Effects of LSD on Perceptual Decision-making in Healthy Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to characterize the effects of low doses of LSD (d-lysergic acid diethylamide) on behavioral and neural indicators of feedback and feedforward signaling in perceptual decision-making.
Detailed description
The study team will subject healthy participants to multiple perceptual decision-making tasks after the administration of low doses of LSD (d-lysergic acid diethylamide) as a pharmacological challenge. The investigators want to illuminate the behavioral and neural effects of psychedelics on prior beliefs and evidence processing. Each subject will participate in 3 x 5 h study sessions separated by at least 7 days. Subjects will be under continuous supervision until approximately 4.5h after substance administration. The participants are asked to perform the following cognitive tasks alongside EEG measurement after administration of either LSD or placebo: Changepoint task, history bias task, surround suppression task, auditory steady-state response paradigm, motor localizer task.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LSD 10 μg | 0.5 h after the start of each study session the participants will be administered 10 μg LSD per os in the form of vials containing 1ml 20% EtOH (ethanol). |
| DRUG | LSD 20 μg | 0.5 h after the start of each study session the participants will be administered 20 μg LSD per os in the form of vials containing 1ml 20% EtOH. |
| DRUG | Placebo | 0.5 h after the start of each study session the participants will be administered placebo per os in the form of vials containing 1ml 20% EtOH. |
Timeline
- Start date
- 2024-02-26
- Primary completion
- 2025-02-25
- Completion
- 2025-02-25
- First posted
- 2023-08-04
- Last updated
- 2025-03-14
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT05976698. Inclusion in this directory is not an endorsement.